Skip to main content
OpenTrials

Clinical trial condition

Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major

Explore clinical trials studying Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major trial results

Completed

Post Hematopoietic Stem Cell Transplantation

NCT01610297

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Izmir, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Antalya, Turkey (Türkiye)
View Trial Details

Related conditions